Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-01 Sale |
2022-12-02 5:52 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $46.07 | $460,700 | 521,016 (Direct) |
View |
| 2022-11-30 Sale |
2022-12-02 5:48 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
23,131 | $46.94 | $1,085,739 | 284,364 (Indirect Direct) |
View |
| 2022-11-15 Sale |
2022-11-16 7:15 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
7,085 | $45.28 | $320,806 | 183,837 (Direct) |
View |
| 2022-11-10 Sale |
2022-11-14 5:26 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $39.42 | $197,105 | 72,073 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-02 9:52 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $43.42 | $434,183 | 531,016 (Direct) |
View |
| 2022-10-28 Sale |
2022-11-01 5:38 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
44,103 | $40.31 | $1,777,829 | 307,495 (Indirect Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 9:50 pm |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
285,487 | $42.71 | $12,193,196 | 351,598 (Indirect Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 9:27 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
15,415 | $45.07 | $694,782 | 314,930 (Direct) |
View |
| 2022-10-25 Sale |
2022-10-27 9:25 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $44.72 | $558,944 | 283,510 (Indirect Direct) |
View |
| 2022-09-13 Sale(A) |
2022-10-27 9:23 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,500 | $29.18 | $656,550 | 296,593 (Direct) |
View |
| 2022-10-13 Sale |
2022-10-17 5:40 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $39.82 | $796,400 | 266,258 (Direct) |
View |
| 2022-10-10 Sale |
2022-10-12 4:59 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $37.99 | $189,950 | 77,073 (Direct) |
View |
| 2022-10-06 Sale |
2022-10-07 6:00 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,500 | $39.29 | $884,025 | 247,665 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 08:55 am |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $33.23 | $332,279 | 541,016 (Direct) |
View |
| 2022-09-30 Sale |
2022-10-04 8:57 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
45,000 | $32.72 | $1,472,400 | 336,593 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:59 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
60,000 | $27.42 | $1,645,444 | 551,016 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:59 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
40,000 | $27.48 | $1,099,228 | 82,073 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:57 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
32,500 | $27.03 | $878,341 | 286,258 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:56 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
22,500 | $29.18 | $656,550 | 223,837 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 8:40 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $17.59 | $175,900 | 609,864 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 7:12 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $17.56 | $175,600 | 619,864 (Direct) |
View |
| 2022-01-14 Sale |
2022-01-18 9:48 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
9,700 | $22.03 | $213,691 | 317,606 (Direct) |
View |
| 2021-01-10 Sale |
2022-01-11 9:40 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $19.55 | $195,500 | 619,864 (Direct) |
View |
| 2021-12-21 Sale |
2021-12-23 9:03 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
100 | $22 | $2,200 | 327,306 (Direct) |
View |
| 2021-12-17 Sale |
2021-12-20 4:54 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
3,200 | $22.04 | $70,528 | 327,406 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-01 Exercise |
2022-12-02 5:52 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 521,016 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 5:52 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 521,016 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-02 9:52 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 531,016 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-02 9:52 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 531,016 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 9:27 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
8,203 | $6.36 | 314,930 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 9:27 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,797 | $28.35 | 314,930 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 9:27 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $0 | 314,930 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 9:25 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $6.36 | 283,510 (Direct) |
View |
| 2022-10-25 Exercise |
2022-10-27 9:25 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $0 | 283,510 (Direct) |
View |
| 2022-09-13 Exercise(A) |
2022-10-27 9:23 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $6.36 | 296,593 (Direct) |
View |
| 2022-09-13 Exercise(A) |
2022-10-27 9:23 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $0 | 296,593 (Direct) |
View |
| 2022-10-13 Exercise |
2022-10-17 5:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $7.009 | 266,258 (Direct) |
View |
| 2022-10-13 Exercise |
2022-10-17 5:40 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
20,000 | $0 | 266,258 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $21.09 | 247,665 (Direct) |
View |
| 2022-10-06 Exercise |
2022-10-07 6:00 pm |
N/A 2029-12-12 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
10,000 | $0 | 247,665 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 08:55 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 541,016 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 08:55 am |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 541,016 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 8:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
13,672 | $21.09 | 336,593 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 8:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
6,328 | $6.36 | 336,593 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-04 8:57 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
20,000 | $0 | 336,593 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-15 7:59 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
60,000 | $0.615 | 551,016 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-15 7:59 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
60,000 | $0 | 551,016 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-15 7:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
32,500 | $7.009 | 286,258 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-15 7:57 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
32,500 | $0 | 286,258 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:16 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
58,148 | $0 | 87,222 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:15 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
58,148 | $0 | 209,295 (Direct) |
View |
| 2022-06-30 Option Award |
2022-09-13 9:15 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
1,152 | $8.03 | 209,295 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:14 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
58,148 | $0 | 91,651 (Direct) |
View |
| 2022-06-30 Option Award |
2022-09-13 9:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
1,152 | $8.03 | 91,651 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:14 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
58,148 | $0 | 333,559 (Direct) |
View |
| 2021-06-30 Option Award |
2022-09-13 9:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,007 | $21.09 | 333,559 (Direct) |
View |
| 2022-06-30 Option Award |
2022-09-13 9:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,152 | $8.03 | 333,559 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:13 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
174,442 | $0 | 571,811 (Direct) |
View |
| 2022-06-30 Option Award |
2022-09-13 9:13 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,152 | $8.03 | 571,811 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:25 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Judy Chou Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-02 8:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 609,864 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-02 8:40 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 609,864 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 7:12 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 619,864 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 7:12 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 619,864 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-18 9:48 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
9,700 | $7.009 | 317,606 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-18 9:48 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
9,700 | $0 | 317,606 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 9:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 619,864 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 9:40 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 619,864 (Direct) |
View |
| 2022-01-07 Exercise |
2022-01-11 4:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
27,744 | $0.615 | 316,074 (Direct) |
View |
| 2022-01-07 Exercise |
2022-01-11 4:40 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
27,744 | $0 | 316,074 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 9:21 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
53,000 | $0.615 | 514,708 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 9:21 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
53,000 | $0 | 514,708 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 9:03 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
100 | $7.009 | 327,306 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 9:03 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
100 | $0 | 327,306 (Direct) |
View |
| 2021-12-17 Exercise |
2021-12-20 4:54 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
3,200 | $7.009 | 327,406 (Direct) |
View |
| 2021-12-17 Exercise |
2021-12-20 4:54 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
3,200 | $0 | 327,406 (Direct) |
View |